Cargando…
Eosinophil‐derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthma
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592754/ https://www.ncbi.nlm.nih.gov/pubmed/32147844 http://dx.doi.org/10.1111/all.14266 |
| _version_ | 1783601246847893504 |
|---|---|
| author | Howarth, Peter Quirce, Santiago Papi, Alberto Israel, Elliot Mallett, Stephen Bates, Stewart Yancey, Steve Albers*, Frank C. Kwon, Namhee |
| author_facet | Howarth, Peter Quirce, Santiago Papi, Alberto Israel, Elliot Mallett, Stephen Bates, Stewart Yancey, Steve Albers*, Frank C. Kwon, Namhee |
| author_sort | Howarth, Peter |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7592754 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75927542020-11-02 Eosinophil‐derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthma Howarth, Peter Quirce, Santiago Papi, Alberto Israel, Elliot Mallett, Stephen Bates, Stewart Yancey, Steve Albers*, Frank C. Kwon, Namhee Allergy Letters to the Editor John Wiley and Sons Inc. 2020-03-23 2020-08 /pmc/articles/PMC7592754/ /pubmed/32147844 http://dx.doi.org/10.1111/all.14266 Text en © 2020 The Authors. Allergy Published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Letters to the Editor Howarth, Peter Quirce, Santiago Papi, Alberto Israel, Elliot Mallett, Stephen Bates, Stewart Yancey, Steve Albers*, Frank C. Kwon, Namhee Eosinophil‐derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthma |
| title | Eosinophil‐derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthma |
| title_full | Eosinophil‐derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthma |
| title_fullStr | Eosinophil‐derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthma |
| title_full_unstemmed | Eosinophil‐derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthma |
| title_short | Eosinophil‐derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthma |
| title_sort | eosinophil‐derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthma |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592754/ https://www.ncbi.nlm.nih.gov/pubmed/32147844 http://dx.doi.org/10.1111/all.14266 |
| work_keys_str_mv | AT howarthpeter eosinophilderivedneurotoxinandclinicaloutcomeswithmepolizumabinsevereeosinophilicasthma AT quircesantiago eosinophilderivedneurotoxinandclinicaloutcomeswithmepolizumabinsevereeosinophilicasthma AT papialberto eosinophilderivedneurotoxinandclinicaloutcomeswithmepolizumabinsevereeosinophilicasthma AT israelelliot eosinophilderivedneurotoxinandclinicaloutcomeswithmepolizumabinsevereeosinophilicasthma AT mallettstephen eosinophilderivedneurotoxinandclinicaloutcomeswithmepolizumabinsevereeosinophilicasthma AT batesstewart eosinophilderivedneurotoxinandclinicaloutcomeswithmepolizumabinsevereeosinophilicasthma AT yanceysteve eosinophilderivedneurotoxinandclinicaloutcomeswithmepolizumabinsevereeosinophilicasthma AT albersfrankc eosinophilderivedneurotoxinandclinicaloutcomeswithmepolizumabinsevereeosinophilicasthma AT kwonnamhee eosinophilderivedneurotoxinandclinicaloutcomeswithmepolizumabinsevereeosinophilicasthma |